Your browser doesn't support javascript.
loading
Uptake, discontinuation, and continuation rate of long-acting contraceptive methods when offered at no cost in Campinas, Brazil.
Laporte, Montas; Marcelino, Ana C; Pereira, Paula da Cunha; Espejo-Arce, Ximena; Juliato, Cassia T; Bahamondes, Luis.
Afiliação
  • Laporte M; Department of Obstetrics and Gynecology, University of Campinas Faculty of Medical Sciences, Campinas, São Paulo, Brazil.
  • Marcelino AC; Department of Obstetrics and Gynecology, University of Campinas Faculty of Medical Sciences, Campinas, São Paulo, Brazil.
  • Pereira PDC; Department of Obstetrics and Gynecology, University of Campinas Faculty of Medical Sciences, Campinas, São Paulo, Brazil.
  • Espejo-Arce X; Department of Obstetrics and Gynecology, University of Campinas Faculty of Medical Sciences, Campinas, São Paulo, Brazil.
  • Juliato CT; Department of Obstetrics and Gynecology, University of Campinas Faculty of Medical Sciences, Campinas, São Paulo, Brazil.
  • Bahamondes L; Department of Obstetrics and Gynecology, University of Campinas Faculty of Medical Sciences, Campinas, São Paulo, Brazil. Electronic address: bahamond@caism.unicamp.br.
Contraception ; 132: 110363, 2024 04.
Article em En | MEDLINE | ID: mdl-38195047
ABSTRACT

OBJECTIVES:

This study aimed to compare the uptake, reasons for discontinuation, continuation, and satisfaction of long-acting contraceptive methods (LARC) when offered at no cost in Campinas, Brazil. STUDY

DESIGN:

This was a prospective cohort study conducted at University of Campinas, Campinas, São Paulo, Brazil, including women aged 18 to 48 years, who adopted one of three methods. Participants underwent telephone follow-up every 3 months for up to 24 months after insertion. Satisfaction was assessed at the end of 2 years of use through the Likert scale.

RESULTS:

We invited 1222 women, and among the 971 women who volunteered to participate in follow-up, 414 (42.6%) chose the levonorgestrel 52-mg intrauterine device (IUD), 358 (36.9%) chose the etonogestrel (ENG) implant, and 199 (20.5%) chose the TCu380A IUD. Discontinuation due to bothersome bleeding was higher among users of the ENG implant (10/358; 2.4%) and the TCu380A IUD (32/199; 8.9%), and expulsion was higher for the TCu380A IUD (30/199; 15.1%). Women continued at 24 months were 340/414 (82.1%), 270/358 (75.4%), and 119/199 (59.8%) among users of the levonorgestrel 52-mg IUD, ENG implant, and TCu380A IUD, respectively. The users of the levonorgestrel 52-mg IUD (301/339, 88.8%), the ENG-implant (222/270, 82.2%), and the TCu380A IUD (105/119, 88.2%) were satisfied or very satisfied by 24 months of follow-up.

CONCLUSIONS:

The three LARC methods had great uptake, high continuation, and discontinuation due to bothersome bleeding was higher among users of the ENG implant and the TCu380A IUD, and expulsion was higher for the TCu380A IUD compared to the 52-mg levonorgestrel IUD. Most of the participants reported being very satisfied. IMPLICATIONS When the LARC methods were offered at no cost in a Brazilian public clinic the uptake, satisfaction and continuation were high by 24 months after device placement, and high level of satisfaction was reported by most of the participants.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Levanogestrel / Dispositivos Intrauterinos Tipo de estudo: Health_economic_evaluation / Observational_studies Limite: Female / Humans País/Região como assunto: America do sul / Brasil Idioma: En Revista: Contraception Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Brasil

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Levanogestrel / Dispositivos Intrauterinos Tipo de estudo: Health_economic_evaluation / Observational_studies Limite: Female / Humans País/Região como assunto: America do sul / Brasil Idioma: En Revista: Contraception Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Brasil